|
Market Closed -
Other stock markets
|
After hours 23:32:25 | |||
| 1.375 USD | -89.77% |
|
1.445 | +5.09% |
| 08-10 | Tenax Therapeutics Announces Topline Results from Phase 3 Level Clinical Trial of Tnx-103 in Patients with Ph-Hfpef | CI |
| 08-10 | Tenax Therapeutics, Inc. - Special Call |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Bullish |
| Resistance | 15.85 | 18.32 | 17.55 |
| Spread/Res. | -91.32% | -92.49% | -92.17% |
| Spread/Supp. | -89.46% | -86.95% | -87.19% |
| Support | 13.05 | 10.54 | 10.73 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- TENX Stock
- Charts Tenax Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
